Home > Insider Trading > Filing (0001209191-16-099612)

Filing Details

Accession Number:: 0001209191-16-099612
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-02-18 06:23:52
Reporting Period:: 2016-02-16

Filing Date:: 2016-02-18
Accepted Time:: 2016-02-18 06:23:52
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1624899	Steris Plc	STE	Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)	981203539

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1413087	Jr M Walter Rosebrough	C/O Chancery House, 190 Waterside Road Hamilton Industrial Park Leiscester X0 LE5 1QZ	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Disposition	2016-02-16	5,000	$63.87	15,000	No	4	S	Indirect	See Footnote Below.
Ordinary Shares	Disposition	2016-02-17	5,000	$64.66	10,000	No	4	S	Indirect	See Footnote Below.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnote Below.
No	4	S	Indirect	See Footnote Below.

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Ordinary Shares	111,376	Direct
Ordinary Shares	68,806	Indirect	See Footnote Below.

Footnotes

This transaction involved the open market sale on February 16, 2016 of a total of 5,000 shares, Held by the Reporting Person as Trustee, from an irrevocable trust established for the benefit of the children of the Reporting Person and the Reporting Person's Spouse, pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person, as Trustee, on September 1, 2015.
This represents the average sales price of the 5,000 shares sold in the open market. The actual 34 sales prices ranged from $63.0700 per share to $64.2100 per share. Issuer, upon request by the SEC staff, will provide full information regarding the number of shares sold at each of these 34 sales prices.
These ordinary shares are held by the Reporting Person as Trustee of an irrevocable trust established for the benefit of the children of the Reporting Person and the Reporting Person's Spouse.
This transaction involved the open market sale on February 17, 2016 of a total of 5,000 shares, Held by the Reporting Person as Trustee, from an irrevocable trust established for the benefit of the children of the Reporting Person and the Reporting Person's Spouse, pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person, as Trustee, on September 1, 2015.
This represents the average sales price of the 5,000 shares sold in the open market. The actual 40 sales prices ranged from $64.1000 per share to $65.0100 per share. Issuer, upon request by the SEC staff, will provide full information regarding the number of shares sold at each of these 40 sales prices.
These 111,376 ordinary shares are held by the Reporting Person as Trustee of a revocable trust established for his benefit. 44,750 of these ordinary shares are restricted. The restrictions on the restricted ordinary shares lapse as follows: 5,000 on May 31, 2016; 6,250 on May 31, 2016; 6,250 on May 31, 2017; 4,250 on May 30, 2016; 4,250 on May 30, 2017, 4,250 on May 30, 2018, 3,625 on May 30, 2016, 3,625 on May 29, 2017, 3,625 on May 28, 2018, and 3,625 on May 28, 2019.
These ordinary shares are held by the Reporting Person's Spouse as Trustee of a revocable trust established for her benefit.